We demonstrated that the in situ preconditioning platform, a combinational platform consisting of BM-MSCs, HGF-eMSCs, and hdECM hydrogel, successfully preserved cardiac function by enhancing vessel formation and minimizing adverse remodeling in post-MI hearts. Here, HGF is linked to myocardial infarction.